• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy

Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

Eshe Nelson
Author: Eshe Nelson

Written by

Eshe Nelson

in

Denmark, Diabetes, Drugs (Pharmaceuticals), Economic Conditions and Trends, Gross Domestic Product, Novo Nordisk A/S, Ozempic (Drug), Semaglutide (Drug)
←Oliver Anthony Music’s ‘Rich Men North of Richmond’ Stays No. 1
France To Ban Muslim Students From Wearing Abayas In Schools→

More posts

  • How Doku became key player for treble-chasing Man City

  • The Eurovision Song Contest reaches its grand final with pop and protests

  • Trump says Islamic State group leader was killed in a joint US-Nigerian mission

  • Would FA Cup win paper over the cracks for Chelsea?

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube